A Physical and Psychological Approach to Managing Fatigue in Myasthenia Gravis: A Pilot Study
- 4 June 2018
- journal article
- Published by SAGE Publications in Journal of Neuromuscular Diseases
- Vol. 5 (3) , 373-385
Abstract
Background: Fatigue in myasthenia gravis (MG) is common and difficult to manage. Unlike myasthenic weakness it is not amenable to drug therapies. Objective: Our primary aim was to investigate whether a combination of physical and psychological therapy would help address symptoms of fatigue in MG patients, who have stable disease but residual problematic fatigue. Our secondary aim was to quantitate fatigue by applying different scores and to ascertain which would be most relevant to apply in MG. Methods: We recruited 10 MG patients with stable disease and who suffer from fatigue. Nine of these 10 patients participated in a 10-week program that involved physical and psychological intervention. We quantified their fatigue using the modified fatigue impact scale (MFIS), the visual analogue fatigue scale (VAFS) and the fatigue severity scale (FSS) at the start of the study, at various intervals during the program and 3 months later. Results: During the program, there was a small improvement in the physical and psychosocial subscale of the MFIS. There was a significant improvement ( p < 0.01) in the VAFS at the end of the program. No clear improvement was noted in FSS. Three months later, all fatigue scores declined to baseline but 50% of patients had made some life-style changes. Conclusions: This is a small pilot study, which utilized a combined approach with physical and psychological therapy, and showed some benefit in improving fatigue in patients with MG. The improvement was small and unsustained. Because of the small patient cohort, one cannot derive any firm conclusions and a larger study is required to investigate this further.Keywords
This publication has 32 references indexed in Scilit:
- Fatigue in myasthenia gravis: is it more than muscular weakness?BMC Neurology, 2013
- Fatigue and daytime sleepiness scale in myotonic dystrophy type 1Muscle & Nerve, 2012
- Association between pro- and anti-inflammatory cytokine genes and a symptom cluster of pain, fatigue, sleep disturbance, and depressionCytokine, 2012
- The MG‐QOL15 for following the health‐related quality of life of patients with myasthenia gravisMuscle & Nerve, 2010
- The MG CompositeNeurology, 2010
- Reliability, Responsiveness, and Validity of the Visual Analog Fatigue Scale to Measure Exertion Fatigue in People with Chronic Stroke: A Preliminary StudyStroke Research and Treatment, 2010
- Shared Decision-MakingWorld Health & Population, 2009
- Myasthenia gravisNeurology, 2000
- Measuring the Functional Impact of Fatigue: Initial Validation of the Fatigue Impact ScaleClinical Infectious Diseases, 1994
- The Hospital Anxiety and Depression ScaleActa Psychiatrica Scandinavica, 1983